查看購物車
  • English
封面
市場調查報告書
商品編碼
1901722

避孕器材市場－全球產業規模、佔有率、趨勢、機會和預測，依產品類型、配銷通路、最終用戶、地區和競爭格局分類，2021-2031年預測

Contraceptive Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Distribution Channel, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球避孕器材市場規模將從2025年的115.4億美元成長到2031年的165.3億美元，複合年成長率為6.17%。避孕器材涵蓋一系列醫療植入物、物理屏障和子宮內避孕系統，旨在透過干擾生殖過程來預防懷孕。

市場概覽
預測期 2027-2031
市場規模：2025年 115.4億美元
市場規模：2031年 165.3億美元
複合年成長率：2026-2031年 6.17%
成長最快的細分市場 隔膜
最大的市場 北美洲

主要市場促進因素

性傳染感染（STI）的日益普及是全球避孕器材市場的重要推動因素，促使人們採用屏障避孕法，同時預防意外懷孕和疾病傳播。感染率的激增迫使公共衛生機構大力推廣使用保險套和其他物理屏障避孕方法，從而維持了與荷爾蒙植入劑或子宮內避孕系統不同的高銷售量。

主要市場挑戰

長效可逆避孕方法（LARCs）的高昂成本以及發展中地區醫療基礎設施的匱乏，嚴重限制了全球避孕器材市場的發展。與短期避孕方法不同，植入式避孕器和子宮內避孕系統需要大量的預付費用，並且需要訓練有素的醫務人員進行植入，因此嚴重依賴外部資金和完善的臨床網路。

主要市場趨勢

可逆男性避孕技術的出現，從根本上改變了整個產業格局，為以女性為中心的避孕方法提供了切實可行的替代方案。這一趨勢的核心在於開發非激素類、血管阻塞性水凝膠，這種水凝膠能夠提供與輸精管結紮術相當的長期避孕效果，同時確保可逆性，從而滿足男性和女性共同承擔生育責任這一尚未得到充分滿足的巨大需求。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球避孕器械市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型（保險套、隔膜、子宮頸帽、海綿、陰道環、子宮內避孕器（IUD）及其他）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房及其他）
    • 按最終用戶（男性和女性）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美避孕器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲避孕器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區避孕器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲避孕器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲避孕器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球避孕器材市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Cooper Surgical, Inc.
  • Pfizer, Inc
  • Merck & Co Inc
  • AbbVie, Inc
  • Teva Pharmaceutical Industries Limited
  • Ansell Ltd
  • Bayer AG
  • Mayer Laboratories Inc
  • Church & Dwight Co Inc
  • Reckitt Benckiser Group plc

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 12871

The Global Contraceptive Devices Market will grow from USD 11.54 Billion in 2025 to USD 16.53 Billion by 2031 at a 6.17% CAGR. Contraceptive devices encompass a spectrum of medical implants, physical barriers, and intrauterine systems designed to prevent pregnancy by interfering with the reproductive process.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.54 Billion
Market Size 2031USD 16.53 Billion
CAGR 2026-20316.17%
Fastest Growing SegmentDiaphragms
Largest MarketNorth America

Key Market Drivers

The rising prevalence of sexually transmitted infections (STIs) acts as a critical catalyst for the Global Contraceptive Devices Market, necessitating the adoption of barrier methods that offer dual protection against both unintended conception and disease transmission. This surge in infection rates compels public health bodies to aggressively promote condom usage and other physical barriers, thereby sustaining high-volume sales distinct from hormonal implants or intrauterine systems. The urgency of this driver is underscored by recent epidemiological data indicating a failure to curb specific transmission rates globally.

Key Market Challenges

The high costs associated with long-acting reversible contraceptives (LARCs) and the limited healthcare infrastructure in developing regions constitute a severe restraint on the global contraceptive devices market. Unlike short-term methods, implants and intrauterine systems require significant upfront expenditure and trained medical personnel for insertion, creating a heavy dependency on external funding and robust clinical networks. When supply chains fracture or donor allocations stagnate, these higher-value devices become inaccessible to the populations that need them most. This financial and logistical disconnect prevents the conversion of potential demand into actual market adoption, effectively capping market volume and revenue potential in high-demand regions.

Key Market Trends

The emergence of reversible male contraceptive technologies is fundamentally altering the sector by introducing viable alternatives to female-centric methods. This trend centers on the development of non-hormonal, vas-occlusive hydrogels that provide long-term efficacy comparable to vasectomies while ensuring reversibility, thereby addressing the significant unmet demand for shared reproductive responsibility. These innovations are progressing rapidly through clinical validation, proving that reliable male-focused devices can effectively disrupt the traditional market reliance on condoms and permanent sterilization.

Key Market Players

  • Cooper Surgical, Inc.
  • Pfizer, Inc
  • Merck & Co Inc
  • AbbVie, Inc
  • Teva Pharmaceutical Industries Limited
  • Ansell Ltd
  • Bayer AG
  • Mayer Laboratories Inc
  • Church & Dwight Co Inc
  • Reckitt Benckiser Group plc

Report Scope:

In this report, the Global Contraceptive Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contraceptive Devices Market, By Product Type:

  • Condoms
  • Diaphragms
  • Cervical Caps
  • Sponges
  • Vaginal Rings
  • Intra Uterine Devices (IUDs)
  • and Others

Contraceptive Devices Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • and Others

Contraceptive Devices Market, By End User:

  • Male
  • and Female

Contraceptive Devices Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contraceptive Devices Market.

Available Customizations:

Global Contraceptive Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contraceptive Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUDs), and Others)
    • 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
    • 5.2.3. By End User (Male, and Female)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Contraceptive Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Contraceptive Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Distribution Channel
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Contraceptive Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Distribution Channel
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Contraceptive Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Distribution Channel
        • 6.3.3.2.3. By End User

7. Europe Contraceptive Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Contraceptive Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Distribution Channel
        • 7.3.1.2.3. By End User
    • 7.3.2. France Contraceptive Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Distribution Channel
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Contraceptive Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Distribution Channel
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Contraceptive Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Distribution Channel
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Contraceptive Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Distribution Channel
        • 7.3.5.2.3. By End User

8. Asia Pacific Contraceptive Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Contraceptive Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Distribution Channel
        • 8.3.1.2.3. By End User
    • 8.3.2. India Contraceptive Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Distribution Channel
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Contraceptive Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Distribution Channel
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Contraceptive Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Distribution Channel
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Contraceptive Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Distribution Channel
        • 8.3.5.2.3. By End User

9. Middle East & Africa Contraceptive Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Contraceptive Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Distribution Channel
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Contraceptive Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Distribution Channel
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Contraceptive Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Distribution Channel
        • 9.3.3.2.3. By End User

10. South America Contraceptive Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Contraceptive Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Distribution Channel
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Contraceptive Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Distribution Channel
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Contraceptive Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Distribution Channel
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Contraceptive Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cooper Surgical, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Pfizer, Inc
  • 15.3. Merck & Co Inc
  • 15.4. AbbVie, Inc
  • 15.5. Teva Pharmaceutical Industries Limited
  • 15.6. Ansell Ltd
  • 15.7. Bayer AG
  • 15.8. Mayer Laboratories Inc
  • 15.9. Church & Dwight Co Inc
  • 15.10. Reckitt Benckiser Group plc

16. Strategic Recommendations

17. About Us & Disclaimer